ArticleArthritis research & therapy2022

Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination.

Olivier Vittecoq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.